Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors

Andrea Ferrari, Ines B. Brecht, Gemma Gatta, Dominik T. Schneider, Daniel Orbach, Giovanni Cecchetto, Jan Godzinski, Yves Reguerre, Ewa Bien, Teresa Stachowicz-Stencel, Michael Ost, Chiara Magni, Pamela Kearns, Gilles Vassal, Maura Massimino, Andrea Biondi, Gianni Bisogno, Annalisa Trama

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Although all tumours are rare in childhood, there are some particularly rare paediatric cancers which have not benefited from advances made by the international paediatric oncology network. To establish a shared definition and produce a list of these entities, the European Union Joint Action on Rare Cancers (JARC) promoted a consensus effort. The definition was based on the incidence rates estimated using the information network on rare cancers (RARECAREnet) database, pooling data from 94 population-based cancer registries and 27 countries. The RARECAREnet list of cancers was used to estimate the incidence rates. This list groups cancers by combining the International Classification of Diseases for Oncology, third edition, morphology and topography codes. According to the consensus, very rare paediatric cancers were identified as those with an annual incidence <2/1000000 and corresponded to 11% of all cancers in patients aged 0–14 years. Two subgroups were identified: tumour types typical of childhood (i.e. hepatoblastoma, pleuropulmonary blastoma, pancreatoblastoma) and those typical of adult age (i.e. carcinomas, melanoma). The threshold of 2/1000000 could also be adopted in populations aged 0–19 years: in this case, three tumour types had an incidence rate which was >2/1000000 (i.e. thyroid and testicular cancers and skin melanoma), but the consensus experts considered them as ‘very rare’ according to their clinical needs (e.g. shortage of knowledge and clinical expertise as the other rare paediatric cancers). The JARC consensus produced a definition and a list of very rare paediatric cancers which may represent a starting point for prioritising research on these tumours, based on data and patients’ clinical needs.

Original languageEnglish
Pages (from-to)120-126
Number of pages7
JournalEuropean Journal of Cancer
Volume110
DOIs
Publication statusPublished - Mar 2019

Fingerprint

Pediatrics
Neoplasms
Incidence
Information Services
Testicular Neoplasms
Skin Neoplasms
International Classification of Diseases
European Union
Thyroid Neoplasms
Registries
Meta-Analysis
Melanoma
Databases
Research
Population

Keywords

  • Cancer registries
  • Consensus
  • Incidence
  • Very rare paediatric cancers

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Defining and listing very rare cancers of paediatric age : consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. / Ferrari, Andrea; Brecht, Ines B.; Gatta, Gemma; Schneider, Dominik T.; Orbach, Daniel; Cecchetto, Giovanni; Godzinski, Jan; Reguerre, Yves; Bien, Ewa; Stachowicz-Stencel, Teresa; Ost, Michael; Magni, Chiara; Kearns, Pamela; Vassal, Gilles; Massimino, Maura; Biondi, Andrea; Bisogno, Gianni; Trama, Annalisa.

In: European Journal of Cancer, Vol. 110, 03.2019, p. 120-126.

Research output: Contribution to journalArticle

Ferrari, A, Brecht, IB, Gatta, G, Schneider, DT, Orbach, D, Cecchetto, G, Godzinski, J, Reguerre, Y, Bien, E, Stachowicz-Stencel, T, Ost, M, Magni, C, Kearns, P, Vassal, G, Massimino, M, Biondi, A, Bisogno, G & Trama, A 2019, 'Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors', European Journal of Cancer, vol. 110, pp. 120-126. https://doi.org/10.1016/j.ejca.2018.12.031
Ferrari, Andrea ; Brecht, Ines B. ; Gatta, Gemma ; Schneider, Dominik T. ; Orbach, Daniel ; Cecchetto, Giovanni ; Godzinski, Jan ; Reguerre, Yves ; Bien, Ewa ; Stachowicz-Stencel, Teresa ; Ost, Michael ; Magni, Chiara ; Kearns, Pamela ; Vassal, Gilles ; Massimino, Maura ; Biondi, Andrea ; Bisogno, Gianni ; Trama, Annalisa. / Defining and listing very rare cancers of paediatric age : consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. In: European Journal of Cancer. 2019 ; Vol. 110. pp. 120-126.
@article{f472024f12ed4b4c95d4681c574e455e,
title = "Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors",
abstract = "Although all tumours are rare in childhood, there are some particularly rare paediatric cancers which have not benefited from advances made by the international paediatric oncology network. To establish a shared definition and produce a list of these entities, the European Union Joint Action on Rare Cancers (JARC) promoted a consensus effort. The definition was based on the incidence rates estimated using the information network on rare cancers (RARECAREnet) database, pooling data from 94 population-based cancer registries and 27 countries. The RARECAREnet list of cancers was used to estimate the incidence rates. This list groups cancers by combining the International Classification of Diseases for Oncology, third edition, morphology and topography codes. According to the consensus, very rare paediatric cancers were identified as those with an annual incidence <2/1000000 and corresponded to 11{\%} of all cancers in patients aged 0–14 years. Two subgroups were identified: tumour types typical of childhood (i.e. hepatoblastoma, pleuropulmonary blastoma, pancreatoblastoma) and those typical of adult age (i.e. carcinomas, melanoma). The threshold of 2/1000000 could also be adopted in populations aged 0–19 years: in this case, three tumour types had an incidence rate which was >2/1000000 (i.e. thyroid and testicular cancers and skin melanoma), but the consensus experts considered them as ‘very rare’ according to their clinical needs (e.g. shortage of knowledge and clinical expertise as the other rare paediatric cancers). The JARC consensus produced a definition and a list of very rare paediatric cancers which may represent a starting point for prioritising research on these tumours, based on data and patients’ clinical needs.",
keywords = "Cancer registries, Consensus, Incidence, Very rare paediatric cancers",
author = "Andrea Ferrari and Brecht, {Ines B.} and Gemma Gatta and Schneider, {Dominik T.} and Daniel Orbach and Giovanni Cecchetto and Jan Godzinski and Yves Reguerre and Ewa Bien and Teresa Stachowicz-Stencel and Michael Ost and Chiara Magni and Pamela Kearns and Gilles Vassal and Maura Massimino and Andrea Biondi and Gianni Bisogno and Annalisa Trama",
year = "2019",
month = "3",
doi = "10.1016/j.ejca.2018.12.031",
language = "English",
volume = "110",
pages = "120--126",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Defining and listing very rare cancers of paediatric age

T2 - consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors

AU - Ferrari, Andrea

AU - Brecht, Ines B.

AU - Gatta, Gemma

AU - Schneider, Dominik T.

AU - Orbach, Daniel

AU - Cecchetto, Giovanni

AU - Godzinski, Jan

AU - Reguerre, Yves

AU - Bien, Ewa

AU - Stachowicz-Stencel, Teresa

AU - Ost, Michael

AU - Magni, Chiara

AU - Kearns, Pamela

AU - Vassal, Gilles

AU - Massimino, Maura

AU - Biondi, Andrea

AU - Bisogno, Gianni

AU - Trama, Annalisa

PY - 2019/3

Y1 - 2019/3

N2 - Although all tumours are rare in childhood, there are some particularly rare paediatric cancers which have not benefited from advances made by the international paediatric oncology network. To establish a shared definition and produce a list of these entities, the European Union Joint Action on Rare Cancers (JARC) promoted a consensus effort. The definition was based on the incidence rates estimated using the information network on rare cancers (RARECAREnet) database, pooling data from 94 population-based cancer registries and 27 countries. The RARECAREnet list of cancers was used to estimate the incidence rates. This list groups cancers by combining the International Classification of Diseases for Oncology, third edition, morphology and topography codes. According to the consensus, very rare paediatric cancers were identified as those with an annual incidence <2/1000000 and corresponded to 11% of all cancers in patients aged 0–14 years. Two subgroups were identified: tumour types typical of childhood (i.e. hepatoblastoma, pleuropulmonary blastoma, pancreatoblastoma) and those typical of adult age (i.e. carcinomas, melanoma). The threshold of 2/1000000 could also be adopted in populations aged 0–19 years: in this case, three tumour types had an incidence rate which was >2/1000000 (i.e. thyroid and testicular cancers and skin melanoma), but the consensus experts considered them as ‘very rare’ according to their clinical needs (e.g. shortage of knowledge and clinical expertise as the other rare paediatric cancers). The JARC consensus produced a definition and a list of very rare paediatric cancers which may represent a starting point for prioritising research on these tumours, based on data and patients’ clinical needs.

AB - Although all tumours are rare in childhood, there are some particularly rare paediatric cancers which have not benefited from advances made by the international paediatric oncology network. To establish a shared definition and produce a list of these entities, the European Union Joint Action on Rare Cancers (JARC) promoted a consensus effort. The definition was based on the incidence rates estimated using the information network on rare cancers (RARECAREnet) database, pooling data from 94 population-based cancer registries and 27 countries. The RARECAREnet list of cancers was used to estimate the incidence rates. This list groups cancers by combining the International Classification of Diseases for Oncology, third edition, morphology and topography codes. According to the consensus, very rare paediatric cancers were identified as those with an annual incidence <2/1000000 and corresponded to 11% of all cancers in patients aged 0–14 years. Two subgroups were identified: tumour types typical of childhood (i.e. hepatoblastoma, pleuropulmonary blastoma, pancreatoblastoma) and those typical of adult age (i.e. carcinomas, melanoma). The threshold of 2/1000000 could also be adopted in populations aged 0–19 years: in this case, three tumour types had an incidence rate which was >2/1000000 (i.e. thyroid and testicular cancers and skin melanoma), but the consensus experts considered them as ‘very rare’ according to their clinical needs (e.g. shortage of knowledge and clinical expertise as the other rare paediatric cancers). The JARC consensus produced a definition and a list of very rare paediatric cancers which may represent a starting point for prioritising research on these tumours, based on data and patients’ clinical needs.

KW - Cancer registries

KW - Consensus

KW - Incidence

KW - Very rare paediatric cancers

UR - http://www.scopus.com/inward/record.url?scp=85061725181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061725181&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2018.12.031

DO - 10.1016/j.ejca.2018.12.031

M3 - Article

C2 - 30785015

AN - SCOPUS:85061725181

VL - 110

SP - 120

EP - 126

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -